STRATEGY FOR IN-VITRO EVALUATION OF THE INTERACTIONS BETWEEN BIOMATERIALS AND COMPLEMENT-SYSTEM

被引:20
作者
LABARRE, D
MONTDARGENT, B
CARRENO, MP
MAILLET, F
机构
[1] UNIV PARIS 13, RECH MACROMOLEC LAB, CNRS, URA 502, F-93430 VILLETANEUSE, FRANCE
[2] HOP BROUSSAIS, IMMUNOPATHOL LAB, INSERM, U28, F-75674 PARIS 14, FRANCE
关键词
D O I
10.1002/jab.770040304
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Because of the importance of complement activation in the induced activation of leukocytes in vivo, determination of the complement-activating capacity of a candidate biomaterial is an important step in evaluating its biocompatibility. In vitro evaluation can be performed in the presence of human serum by means of techniques described in the literature and reviewed in this paper. Certain physical and chemical parameters involved in complement activation by materials have to be assessed: the chemical composition of the surface, surface area in contact with serum, temperature and duration of contact, and ionic environment with emphasis on divalent ions. Concerning materials evaluation, the adsorption of complement proteins or protein fragments has to be determined in addition to activation. Following screening tests using CH50 determination, activation of both classical and alternative pathways leading to formation of C3 convertases and formation of C5 convertase should be assessed. An example of the determination of the complement-activating capacity of two hydroxylated materials is presented and guidelines for in vitro evaluation are proposed. (C) 1993 John Wiley & Sons, Inc.
引用
收藏
页码:231 / 240
页数:10
相关论文
共 42 条
[1]  
BHAKDI S, 1988, J IMMUNOL, V141, P3117
[2]   PLASMA INTERLEUKIN-1 ACTIVITY DURING HEMODIALYSIS - THE INFLUENCE OF DIALYSIS MEMBRANES [J].
BINGEL, M ;
LONNEMANN, G ;
KOCH, KM ;
DINARELLO, CA ;
SHALDON, S .
NEPHRON, 1988, 50 (04) :273-276
[3]   ADSORPTION OF THROMBIN FROM BUFFER AND MODIFIED PLASMA TO POLYSTYRENE RESINS CONTAINING SULFONATE AND SULFAMIDE ARGINYL METHYL-ESTER GROUPS [J].
BOISSON, C ;
JOZEFONVICZ, J ;
BRASH, JL .
BIOMATERIALS, 1988, 9 (01) :47-52
[4]  
Bommer J, 1987, Contrib Nephrol, V59, P154
[5]   EXVIVO BIOCOMPATIBILITY EVALUATION OF A NEW MODIFIED CELLULOSE MEMBRANE [J].
BOSCH, T ;
SCHMIDT, B ;
SPENCER, PC ;
SAMTLEBEN, W ;
PELGER, M ;
BAURMEISTER, U ;
GURLAND, HJ .
ARTIFICIAL ORGANS, 1987, 11 (02) :144-148
[6]   THE ABILITY OF SEPHADEX TO ACTIVATE HUMAN-COMPLEMENT IS SUPPRESSED IN SPECIFICALLY SUBSTITUTED FUNCTIONAL SEPHADEX DERIVATIVES [J].
CARRENO, MP ;
LABARRE, D ;
JOZEFOWICZ, M ;
KAZATCHKINE, MD .
MOLECULAR IMMUNOLOGY, 1988, 25 (02) :165-171
[7]   SPECIFIC ANTIBODIES ENHANCE SEPHADEX-INDUCED ACTIVATION OF THE ALTERNATIVE COMPLEMENT PATHWAY IN HUMAN-SERUM [J].
CARRENO, MP ;
MAILLET, F ;
LABARRE, D ;
JOZEFOWICZ, M ;
KAZATCHKINE, MD .
BIOMATERIALS, 1988, 9 (06) :514-518
[8]   REGULATION OF THE HUMAN ALTERNATIVE COMPLEMENT PATHWAY - FORMATION OF A TERNARY COMPLEX BETWEEN FACTOR-H, SURFACE-BOUND C3B AND CHEMICAL GROUPS ON NONACTIVATING SURFACES [J].
CARRENO, MP ;
LABARRE, D ;
MAILLET, F ;
JOZEFOWICZ, M ;
KAZATCHKINE, MD .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (11) :2145-2150
[9]  
Cazenave J.-P., 1986, BLOOD SURFACE INTERA
[10]  
Chenoweth D E, 1987, Contrib Nephrol, V59, P51